Skip to main content
Meta navigation
Contact
Donate
Jobs
Main navigation
For patients
For researchers
About us
Network
New anticancer treatment
10 currently open clinical trials
Combined therapy for mantle cell lymphoma
SAKK 36/13
Radio-chemotherapy improvement for locally advanced rectal cancer
SAKK 41/16
Dosage of a new targeted drug for the treatment of lung cancer
SAKK 19/16
A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
Stimulating the immune system to fight against squamous cell carcinoma
SAKK 11/16
NAPAGE: Nab-paclitaxel and gemcitabine for advanced soft tissue sarcomas
SAKK 57/16
Determination of the maximum tolerated dose of a new Microtubule Targeting Agent on adult patients with a recurrent solid tumor
SAKK 67/15
A phase I trial of LY3200882 in patients with solid tumors (oral TGFβ inhibitor)
SAKK 68/17
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Combination therapy with copanlisib and venetoclax in B-cell non-Hodgkin’s lymphoma
SAKK 66/18
All cancer types
Mobile main navigation
For patients
For patients
Participate in a trial
Genetic Counceling
FAQ
Glossary
Downloads
For researchers
For researchers
Research groups
Young Oncology Academy
Grants and fellowships
Electronic Data Capture (EDC)
About us
About us
Mission statement
Organization
Board and Executive Board
Patient Advisory Board
Support and collaborations
Media and publications
Network
Mobile meta navigation
Contact
Donate
Jobs
Vacancies
Work for us
Our values
Work–life balance
Wages and benefits
Staff development
Mobile footer navigation
Imprint
EN
DE
FR
Mobile quicklinks
Trials
Events
News
Portal
Quicklinks
Trials
Events
News
Portal